CPSF7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.462300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.021600E-01
Normal-vs-Stage2
3.626200E-01
Normal-vs-Stage3
6.818400E-02
Normal-vs-Stage4
5.187400E-01
Stage1-vs-Stage2
7.735000E-01
Stage1-vs-Stage3
1.433690E-02
Stage1-vs-Stage4
2.449400E-01
Stage2-vs-Stage3
3.570300E-02
Stage2-vs-Stage4
1.939620E-01
Stage3-vs-Stage4
1.132320E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.085900E-02
Normal-vs-AfricanAmerican
2.339600E-01
Normal-vs-Asian
7.896300E-02
Caucasian-vs-AfricanAmerican
8.350400E-01
Caucasian-vs-Asian
3.915800E-01
AfricanAmerican-vs-Asian
4.763400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.569600E-01
Normal-vs-Female
8.312200E-02
Male-vs-Female
4.755400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.122400E-01
Normal-vs-Age(41-60Yrs)
4.485600E-01
Normal-vs-Age(61-80Yrs)
4.935700E-02
Normal-vs-Age(81-100Yrs)
3.187800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.135200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.438400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.814800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.588300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.909900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.203200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.046800E-01
Normal-vs-Daily Drinker
3.687800E-02
Normal-vs-Weekly Drinker
1.003830E-01
Normal-vs-Occasional Drinker
4.793400E-01
Normal-vs-Social Drinker
4.556200E-01
Non Drinker-vs-Daily Drinker
7.673800E-01
Non Drinker-vs-Weekly Drinker
6.139800E-01
Non Drinker-vs-Occasional Drinker
8.036200E-02
Non Drinker-vs-Social Drinker
8.661900E-02
Daily Drinker-vs-Weekly Drinker
8.088000E-01
Daily Drinker-vs-Occasional Drinker
1.230370E-01
Daily Drinker-vs-Social Drinker
1.715010E-01
Weekly Drinker-vs-Occasional Drinker
2.375400E-01
Weekly Drinker-vs-Social Drinker
3.533800E-01
Occasional Drinker-vs-Social Drinker
5.341200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.343800E-01
Normal-vs-Grade 2
5.949400E-01
Normal-vs-Grade 3
5.466400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.969000E-01
Grade 1-vs-Grade 3
5.307400E-01
Grade 1-vs-Grade 4
3.343800E-01
Grade 2-vs-Grade 3
1.604550E-01
Grade 2-vs-Grade 4
5.949400E-01
Grade 3-vs-Grade 4
5.466400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.000800E-01
Normal-vs-NonDiabetic
4.629700E-02
Diabetic-vs-NonDiabetic
1.109570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.451960E-01
Normal-vs-NoPancreatitis
3.218400E-02
Pancreatitis-vs-NoPancreatitis
4.422000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.677640E-01
Normal-vs-N1
3.538800E-01
N0-vs-N1
2.747000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.195400E-01
Normal-vs-TP53-NonMutant
2.526400E-01
TP53-Mutant-vs-TP53-NonMutant
8.634000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
